Ahmed N., Dobler D., Dean M., Thornalley P. J. (2005) Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem. 280:5724-5732.

(1)

VII. BIBLIOGRAFIA

(2)

Ahmed N., Dobler D., Dean M., Thornalley P. J. (2005) Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem. 280:5724-5732.

Bakhtiar R., Randall W. N. (2001) Mass spectrometry of the proteome.

Novartis Institute for Biomedical Research, East Hanover, New Jersey (R. B.): and intrinsic Bioprobes, Inc., Tempe, Arizona (R.W.N.).

60:317-339.

Bast R. C. Jr, Urban N., Shridhar V., Smith D., Zhang Z., Skates S., Lu K., Liu J., Fishman D., Mills G. (2002) Early detection of ovarian cancer : promise and reality. Cancer Treat Res. 107:61-97.

Baynes J. W., Thorpe S. R. (1981) Identification of the sites of albumin catabolism in the rat. Arch Biochem Biophys. 206:372-379.

Bent-Hansen L., Feldt- Rasmussen B., Kverneland A., Deckert T. (1993) Plasma disappearance of glycated and non glycated albumin in type 1 (insulin-dependent) diabetes mellitus: evidence for charge dependent alterations of the plasma to lymph pathway. Diabetologia. 36:361- 363.

Bocci V. (1967) Biological behaviour of rabbit

¹³¹

albuminpolymers. Arch Biochem Biophys. 120:621-637.

Bradford M. M. (1976) A rapid and sensitive method for the quantitation of migrogram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem. 72: 248.

Brennan S. O., Myles T., Peach R. J., Donaldson D., George P. M. (1990) Albumin Redhill (-1 Arg, 320 Ala-Thr): a glycoprotein variant of human seruma lbumin whose precursor has an aberrant signal peptidase cleavage site. Proc Nat Acad Sci USA. 87:26-30.

Brown J. R., Shockley P. (1982) Serum albumin: structure and characterization of its ligand binding sites (P. Jost and O. H. Griffith eds.) Lipid-protein interactions. 1:25-68.

Candiano G., Musante L., Bruschi M., Petretto A., Cantucci L., Del Boccio B., Pavone B., Per fumo F., Urbani A., Scolari F., Ghiggeri G. M.

(2006). Ripetitive fragmentation products of albumin and α1- antitrypsin in glomerular disease associated with nephrotic syndrome.

J Am Soc Nephrol. 17:3139-3148.

Carter D. C., Ho J. X. (1994) Structure of Serum Albumin. Adv Protein Chem. 45: 153-203.

Cheng S., Coyne D. (2007) Vitamin D and outcomes in chronic kidney

disease. Curr Opin Nephrol Hypertens. 16(2):77-82.

(3)

Clark W. R., Winchester J. F. (2003) Middle molecules and small- molecular-weight proteins in ESRD: properties and strategies for their removal. Adv Ren Replace Ter. 10(4):270-278.

Daly M. B., Ozols R. F. (2002) The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics. Cancer Cell. 2: 111-112.

De Bruyn P. P., Michelson S., Bankston P. W. (1985) In-vivo endocytosis by bristle-coated pits and intracellular transport of endogenous albumin in the endothelium of the sinuses of liver and bone marrow.

Cell Tissue Res. 240:1-7.

De Sain-van der Velden M. G., Rabelink T. J., Rejingould D. J., Gadellaa M. M., Voorbij H. A., Stellaard F., Kaysen G. A. (1998) Plasma alpha 2 macroglobulin is increased in nephrotic patients as a results of increased synthesis alone. Kidney Int. 54(2):530-5.

Deen W. M., Bohrer M. P., Brenner B. M. (1979) Macromolecule transport across glomerular capillaries: application of pore theory. Kidney Int.

16:353-365.

DoyenN., Lapresle C., Lafaye P., Mazie J. C. (1985) Study of the antigenic structure of human serum albumin with monoconal antibodies. Mol.

Immunol. 22:1-10.

Dubrow A., Levin N. W. (1997) Biochemical and hormonal alterations in chronic renal failure. The Principles and Practice of Nephrology.

Jacobson H. R., Striker G. E., Klahr S. Second Edition. section 13, chapter 89:596-603.

Era S., Kuwata K., Imai H., Nakamura K., Hayashi T., Sogami M. (1995) Age related change in redox state of human serum albumin. Biochim Biophys Acta. 1247:12-16.

Frank S., Renner T, Ruppert T., Scherer G. (1998) Determination of albumin adduct of (+)-anti-benzo[a]pirene-diol-epoxido using an high performance liquid cromatographic column switching technique for sample preparation and gas chromatographic-mass spectrometry for the final detection. Journal ofChromatography B. 713: 331-337.

Fukagawa M., Nakanishi S., Fujii H., Hamada Y., Abe T. (2006) Regulation of parathyroid function in chronic kidney disease (CKD). Clin Exp Nephrol. 10:175-179.

Galliano M., Kragh-Hansen U., Tarnoky A. L., Chapman J., Campagnoli M., Minchiotti L. (1999) Genetic variants showing apparent hot spots in the human serum albumin gene. Clin Chim Acta. 289:44-45.

Glannon J. D., Sarkar B. (1982) Nikel(II) transport in human blood serum.

Studies of nikel(II) binding to human albumin and to native-sequence

(4)

peptide, and ternary complex formation with L-histidine. Biochem J.

203:15-23.

Goldsworthy P. D., Volwiler W., (1958)Mechanism of protein turnover studied with cystine-

³⁵

S, lysine-

¹⁴

C doubly labeled plasma protein of the dog. J Biol Chem. 230:817-831.

Gonzàlez-Jimènez J., Cortijo M. (Feb. 2002) Urea-induced denaturation of Human Serum Albumin labeled with Acrylodan. Journal of protein chemistry. 21(2):75-79.

Gorg A., PostelW., Gunther S. (1988) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis.

9:351.

Haliwell B. (1988) Albumin - an important extracellular antioxidant?

Biochemical Pharmacology. 37(34):569-571.

Hamilton J. A., Era S., Bhamidipati S. P., Reed R. G. (1991) Location of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Procl. Natl. Acad. Sci. USA 88:2051-2054.

Harding J. J. (1985) Nonenzymatic covalent posttraslational modification of proteins in vivo. Adv. Protein Chem. 37: 247-334.

Helms M. K., Petersen C. E., Bhagavan N. V., Jameson D. M. (1997) Time- resolved fluorescence studies on site directed mutants of human serum albumin. FEBS Letters. 408:67-70.

Himmelfarb J., McMonagle E. (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 60:358-363.

Indridason O. S., Quarles L. D. (2002) Hypophosphatemia in end-stage renal disease. Adv Ren Replace Ther. 9(3):184-192.

Iwao Y., Anraku M., Yamasaki K., Kragh-Hansen U., Kawai K., Maruyama T., Otagiti M. (2006a) Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochim et Biophys Acta. 1764:743-749.

Iwao Y., Anraku M., Hiraike M., Kawai K., Nakajou K., Kai T., Suanega A., Otagiri M. (2006b) The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products. Drug Metab Pharmacokinet. 21(2):140-146.

Jansen R. W., Molema G., Harms G., Kruijt J. K., van Berkel T. J., Hardonk

M. J., Meijer D. K. (1991) Formaldehyde treated albumin contains

monomeric and polymeric forms that are differently cleared by

endothelial and Kupffer cells of the liver: evidence for scavenger

receptor heterogeneity. Biochem Biophys Res Commun. 180:23-32.

(5)

Jeffries G. H., Halstead M. R. C. P., Holman H. R., Sleisenger M. H. (1962) Plasma proteins and the gastrointestinal tract. N EnglJ Med. 266:656- 660.

Judah J. D., Quinn P. S. (1978) Calcium ion-dependent vescicle fusion in the conversion of pro-albumin to albumin. Nature. 271:384-385.

Kanwar Y. S. (1984) Biology of disease: biophysiology of glomerular filtration and proteinuria. Lab Invest. 51:7-21.

Katz J., Rosenfeld S., Sellers A. L. (1960) Role of the kidney in plasma albumin catabolism. Am J Physiol. 198:814-818.

Katz J., Rosenfeld S., Sellers A. L. (1961) Sites of plasma albumin catabolism in the rat. Am J Physiol. 200:1301-1306.

Kausler E., Spiteller G. (1991) Fragments from albumin and beta-2- microglobulin constituents of the middle molecule fraction of hemofiltration. Biol Chem Hoppe-Seyler. 372:849.

Kaysen G. A., Greene T., Daugirdas J. T., Kimmel P. L., Schulman G. W., Toto R., D., Levin N. W., Yan G. (2003) Longitudinal and cross- sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 42(6):1200-1211.

Khan M. M., Tyyab S. (2001) Understanding the role of internal lysine residues of serum albumins in conformational stability and bilirubin binding. Biochimica et Biophysica Acta. 1545:263-277.

Kragh-Hansen U., Brennan S. O., Minchiotti L., Galliano M. (1994) Modified high-affinity binding of Ni2+, Ca2+ and Zn2+ to natural mutants of human serum albumin and proalbumin. Biochem J.

301:217-242.

Kragh-Hansen U. (1990) Structure and ligand binding properties of human serum albumin. (Review). Dan. Med. Bull. 37:57-84.

Kragh-Hansen U., Donaldson D., Jensen P. H. (2001) The glycan structure of albumin Redhill, a glicosilated variant of human serum albumin.

Biochim Biophys Acta. 1550:20-26.

Kshirsagar B., Wilson B., Wiggins R. C., (1984) Polymeric complexes and fragments of albumin in normal human plasma. Clin Chem Acta.

143:265-273.

Laemmli U. K. (1970) Cleavage of structural proteins during the assembly

of the head of bacteriophage T4. Nature. 227:680.

(6)

Levine R. L., Williams J. A., Stadtman E. R., Shacter E. (1994) Carbonyl assay for determination of oxidatively modified proteins. Methods Enzymol. 233:346-363.

Lightner D. A., Wijekoon W. M., Zhang M. H. (1988) Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin complexes qith bilirubin and its esters. J Biol Chem.

263:16669-16676.

Locatelli F., Pisoni R. L., Combe C., Bommer J., Piera L., Greenwood R., Feldman H. I., Port F. K., Held P. J. (2004) Anaemia in hemodialysis patients of five european countries: association with morbidity and mortality in the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 19(1):121-132.

Lum H., Siflinger-Birnboim A., Blumenstock F., Malik A. B. (1991) Serum albumin decreases transendothelial permeability to macromolecules.

Microvasc Res. 42(1):91-102.

Maack T., Johnson V., Kau S. T., Figueiredo J., Sigulem D. (1979) Renal Filtration, transport and metabolism of low-molecular-weight proteins: a review. Kidney Int. 16:251-270.

Mariani G., Bianchi R. (1982) An overview on the biology and pathophysiology of human albumin. Medical Scientific Direction of Immuno S.p.A., Pisa.

Martin-Mateo M. C., Sanchez-Portugal M., Iglesias S., de Paula A., Bustamante J. (1999) Oxidative stress in chronic renal failure. Ren Fail. 21:155-167.

Maunsbach A. B. (1966) Adsorption of I-125-labeled homologous albumin by rat kidney proximal tubule cells. A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry. J Ultrastruct Res. 15:197-241.

Mcgarry E., Sehon A. H., Rose B. (1955) The isolation and electrophoretic characterization of the proteins in the urine of normal subjects. J Clin Invest. 34:832-844.

Mehrota R., Kopple J. D., Wolfson M. (2003) Metabolic acidosis in manteinance dialysis patients:clinical considerations. Kidney Int Suppl. 88:S13-S25.

Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Otagiri M.

(2005) The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stres via neutrophil burst. Biochem and Biophys Res Communication.

334:1322-1328.

(7)

Miller F., Palede G. E. (1964) Lytic activities in renal protein absorption droplets, an electron microscopical cytochemical study. J Cell Biol.

23:519-522.

Mircescu G., Capusa C., Stoian I., Vargolici B., Barbulescu C., Ursea N.

(2005) Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol. 18:599-605.

Misato K., Masafumi M., Masayasu I. (1997) Effect of Nitric Oxide on the Ligand-Binding Activity of Albumin. Archives of Biochemistry and Biophysics. 345(2):237-242.

Mitch W. E. (2006) Proteolytic mechanism, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr. 16(3):208-211.

Morena M., Cristol J-P., Canaub B. (2000) Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif. 18:191-199.

Mulvihill J. N., Faradji A., Oberling F., Cazenave J. P. (1991) Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimentaland clinical studies. J Biomed Mater Res 24(2):155-63.

Musso C. G. (2004) Potassium metabolism in patients with chronic kidney disease. Part II:patients on dialysis(stage 5). Int Urol Nephrol.

36(3):469-472.

Oliver J., Macdowell M., Lee Y. C. (1954) Cellular mechanism of protein methabolism in the nephron. The structural aspects of proteinuria;

tubular adsorption, droplet formation, and the disposal of proteins. J Exp Med. 99:589-604.

Osicka T. M., Comper W. D. (2004) Characterization of immunochemically nonreactive urinary albumin. Clinical Chemistry.

50(12):2286-2291.

Pedersen K. O. (1972) Binding of calcium to serum albumin. III. Influence of ionic strenght and ionic medium. Scand J Clin Lab Invest. 30: 89- 94.

Pepiptas I., Grune T., Bhattacharya A. A., Curry S. (2001) Crystal structure of human serum albumin complexed with monounsatured and polyunsatured fatty acids. Academic Press.

Perco P., Pleban C., Kainz A., Lukas A., Mayer G., Mayer B., Oberbauer R.

(2006) Protein biomarker associated with acute renal failure and chronic kidney disease. Eur J Clin Invest. 36(11):753-763.

Peters T. Jr (1997) All about albumin. Biochemistry, Genetics, and Medical

(8)

Peters T. Jr. (1987) Intracellular Precursor forms of plasma proteins: their functions and possible occurrence in plasma. Clin Chem. 33: 1317- 1325.

Petricoin E. F., Ardekani A. M., Hitt B. A., Levine P. J., Fusaro V. A., Steibnerg S. M., Mills G. B., Simone C., Fishman C. A., Kohn E. C., Lotta L. A. (2002) Use of proteomic patterns in serum to identità ovarian cancer. Lancet. 359:572-577.

Pierce W. M., Cai J. (2004) Applications of Mass Spectrometry in Proteomics. Thongboonkerd V., Klein J. B. (eds): Proteomics in Nephrology. 141:40-58.

Polanska B., Malulska I., Zwolinska D., Jankowsky A., Niemczuck M.(2001)Neutrophil proteolitic activity in patients on hemodialysis (HD). Abstract Book of the XXXVIII ERA-EDTA Congress, Vienna;

264. Polevoda B., Sherman F. (2003) N-terminal acetyltransferases and sequenze requirements for N-terminal acetylation of eukaryotic proteins. J Biol Mol. 325:595-622.

Poon T. C., Johnson P. J. (2002) Proteome analysis and its impact on the discovery of serological tumor markers. Clin Chim Acta. 313:231-239 Reed R. G., MacKay C. M. (1985) Locating the bilirubin binding site of

human serum albumin. Fed Proc. 44:1618.

Sadler P. J., Tucker A., Viles J. H. (1994) Involvement of a Lysin residue in the N-terminal Ni

²⁺

and Cu

²⁺

binding site of serum albumins.

Comparison with Co

²⁺

, Cd

²⁺

and Al

³⁺

. Eur J Biochem 220:193-200.

Schnitzer J. E., Bravo J. (1993) High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors. J Biol Chem. 268:7562- 7570.

Sechi S. (2004) Mass Spectrometry Approaches to quantitative proteomics.

Thongboonkerd V., Klein J. B. (eds): Proteomics in Nephrology.

141:59-78.

Smeets M. B., Fontijn J., Kavelaars A., Pasterkamp G., Dekleijn D. P. V.

(2003) The acute phase protein Haptoglobulin is locally expressed in arthritic and oncological tissues. Int J Exp Path. 84:69-74.

Sollenne N. P., Wu H. L., Means G. E. (1981) Disruption of the tryptophan

binding site in the human serum albumin dimer. Arch Biochem

Biophys. 207: 264- 269.

(9)

Soni N., Margarson M. (2004) Albumin: where are we now? Current Anaesthesia and Critical Care. 15:61-68.

Sonnenschein C., Soto A. M., Michaelson C. L. (1996) Human serum albumin shares the properties of estrocolione-I, the inibitor of the proliferation of estrogen-target cell. J Steroid Biochem Mol Biol.

59:147-154.

Stamler J. S., Jaraki O., Osborne J., Simion D., Keany J., Vita J., Singel D., Valeri C. R., Loscalzo J. (1992) Nitric oxide circulates in mammalian plasmaprimarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 89:7674-7677.

Sudlow G., Birkett D. J., Wade D. N. (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol.

12:1052-1061.

Tanaka M., Yamazaki M., Hayashino Y., Fukuhara S., Akiba T., Saito A., Asano Y., Port F. K., Kurokawa K., Akizawa T. (2007) Hypercalcaemia is associated with poor mental health in hemodialysis patients:results from Japan DOPPS. Nephrol Dial Transplant. [Epub ahead of print].

Ward R. A., McLeish K. R. (2003) Oxidant stress in hemodialysis patients:

what are the determining factors? Artificial Organs. 27(3):230-236.

Whittaker M. (1968) Serum haptoglobin in the nephrotic syndrome. Other renal diseases and rheumatoid arthritis. Am J Clin Patol. 50(4):454-8.

Witko-Sarsat V., Friedlander M., Nguyen Khoa T., Capeillere-Blandin C., Nguyen A. T., Canteloup S., Dayer J. M., Jungers P., Drueke T., Descamps-Latscha B. (1998) Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure. The Journal of Immunology. 161:2524-2532.

Yamada K., Matsuoka Y., Yamamoto T., Kawana T., Ishii K., Ishimi Y., Ikegami S. (1997) Elevation of Plasma Retinol Binding Protein concentration in experimental acute renal failure. Nutrition Research.

17(10):1555-1567.

Yan J. X., Wait R., Berkelman T., Harry R. A., Westbrook J. A., Wheeler C.

H., Dunn M. J. (2000) A modified silver staining protocol for visualizing of proteins campatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry.

Electrophoresis. 21:3666.

Yedgar S., Carew T. E., Pittman R. C., Beltz W. F., Steinberg D. (1983) Tissue sites of catabolism of albumin in rabbits. Am J Physiol.

244:E101-E107.

(10)

Yuki O., Tomoyuki N., TadayasuT., Kazuyuki I. (2006) Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stress. Biochem and Biophys Res Communication. 340:353-358.

Zoellner H., Hou J. H., Hochgrebe T., Polijak A., Duncan M. W., Golding J., Henderson T., Lynch G. (2001) Fluorimetric and mass spectrometric analysis of nonenzymatic glycosylated albumin.

Biochem Biophys Res Commun. 284: 83-89.